Long-term care is expensive. By expensive, I mean break-the-bank expensive. As people begin to live longer, they don’t always live well longer. Medical science can keep people alive long after they are no longer able to function. The lack of affordable long-term care is a problem that has no easy solution.
Included in Friday Links (November 10) was the title, “Would coverage for gene therapies make employer-based health insurance unaffordable?” That raises an important question: How much should employers (and employees) be required to pay for hyper-expensive therapies very few people need? A related question: should the purpose of employee health coverage be to recruit and retain workers or fund rare disease research and therapies?
A Crisis of Confusion is proving costly for American health care consumers. Dylan Scott of Vox Media wrote about how health care consumers don’t, won’t or can’t navigate the health care system in ways that could save them money. He is correct.